NON-VARICOSE BLEEDING FROM THE UPPER GASTROINTESTINAL TRACT
Introduction. Non-variceal upper gastrointestinal bleeding (NVUGIB) is one of the most critical issues in emergency surgery. This pathology is characterized by a high prevalence and significant mortality rates, especially among elderly patients and individuals with comorbid conditions.
Aim. To study the treatment outcomes of patients with non-variceal upper gastrointestinal bleeding.
Materials and methods. A retrospective study was conducted among n = 667 patients who received inpatient treatment at the surgical department of the City Emergency Hospital in Almaty from January 1, 2019, to December 31, 2023. Mean values (M ± m) and differences between arithmetic means were assessed using Student’s t-test. The relationship between clinical parameters and outcomes was evaluated using the chi-square (χ²) test. Risk factors for adverse outcomes (mortality, rebleeding, need for surgical treatment) were analyzed using logistic regression. The impact of factors was assessed by calculating the odds ratio (OR) with a 95% confidence interval (95% CI). A p-value < 0.05 was considered statistically significant.
Results. The primary causes of bleeding were acute ulcers (60.4%), Mallory-Weiss syndrome (20.4%), chronic ulcers (13.2%), and bleeding of unknown etiology (6.0%). According to the Forrest classification, the most common form was IIB (54.5%). The overall rebleeding rate was 6.9%, while the total mortality rate was 3.6%. Mortality rates by etiology were as follows: acute ulcers – 2.7%, chronic ulcers – 5.6%, Mallory-Weiss syndrome – 0.7%, and bleeding of unknown etiology – 17.5%. The average surgical intervention rate during the study period was 2.8%.
Conclusions. Thus, non-variceal upper gastrointestinal bleeding remains a pressing issue in gastroenterology and surgery, requiring a comprehensive approach to diagnosis and treatment. The study confirmed the high prevalence of peptic ulcer disease, Mallory-Weiss syndrome, and erosive lesions as leading causes of bleeding. The main risk factors for NVUGIB include the use of anticoagulants, nonsteroidal anti-inflammatory drugs, and cardiovascular diseases, highlighting the necessity of careful medication management in patients at high risk of bleeding.
Количество просмотров: 401
Категория статей:
Оригинальное исследование
Библиографическая ссылка
Ibekenov O.T., Baymakhanov A.N., Berkinbay A.B., Zheldibaev Ye.M., Duisebekov M.K., Esenbekov N.B., Zhorayev T.S. Non-varicose bleeding from the upper gastrointestinal tract // Nauka i Zdravookhranenie [Science & Healthcare]. 2025. Vol.27 (1), pp. 66-74. doi 10.34689/SH.2025.27.1.008Похожие публикации:
EPIDEMIOLOGY, RESOURCE DISTRIBUTION, AND MANAGEMENT CHALLENGES OF CHRONIC HEART FAILURE IN KAZAKHSTAN: A NATIONAL RETROSPECTIVE ANALYSIS
PREVALENCE OF POLYMORPHISMS IN WARFARIN METABOLISM-RELATED GENES AMONG THE KAZAKH POPULATION
NEUROLOGICAL COMPLICATIONS IN EXTRACORPOREAL MEMBRANE OXYGENATION: RISK FACTORS FOR THE DEVELOPMENT OF ACUTE CEREBROVASCULAR EVENTS
THE EFFECT OF REPAGLINIDE AND METFORMIN ON EXTERNAL RESPIRATORY FUNCTION IN PATIENTS WITH DIABETES AND ISCHEMIC HEART DISEASE ASSOCIATED WITH OBESITY
RETROSPECTIVE ANALYSIS OF PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF THE LOWER EXTREMITY ARTERIES IN THE ABAI REGION OF THE REPUBLIC OF KAZAKHSTAN